Evidence map›Paper›PMID 40078254›Full record

ArticleCureus2025

Prolonged Elimination of Lamotrigine After Suicidal Overdose: A Case Report.

Hiroshi Mae, Mizuho Namiki, Mitsuru Shiokawa, Munekazu Takeda, Shusuke Mori

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroshi MaeDepartment of Pharmacy, Tokyo Women's Medical University, Tokyo, JPN.
Mizuho NamikiDepartment of Critical Care and Emergency Medicine, Tokyo Women's Medical University, Tokyo, JPN.
Mitsuru ShiokawaDepartment of Pharmacy, Tokyo Women's Medical University, Tokyo, JPN.
Munekazu TakedaDepartment of Critical Care and Emergency Medicine, Tokyo Women's Medical University, Tokyo, JPN.
Shusuke MoriDepartment of Critical Care and Emergency Medicine, Tokyo Women's Medical University, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lamotrigine (LTG) is an antiepileptic drug that stabilizes neuronal membranes by inhibiting excitatory neurotransmitter release, thereby reducing neuronal excitation. Various factors can contribute to its metabolic dysfunction. A 22-year-old female with bipolar disorder presented after intentionally ingesting 216 tablets, including LTG (4,100 mg), prescribed antipsychotics, over-the-counter cold medicine containing acetaminophen (27 g), and alcohol. She arrived at the hospital approximately one-hour post-ingestion in a confused state, with mild transaminase elevation but no significant electrocardiographic abnormalities. Initial management included activated charcoal, N-acetylcysteine therapy, and intravenous fluids. Despite these interventions, she deteriorated to a comatose state by hospital day two, accompanied by a mild skin rash later diagnosed as urticaria. Her hepatic function and consciousness gradually improved, with transaminase normalization and full neurological recovery by day six. She was discharged on day seven without residual deficits. Serial LTG serum measurements at 13, 55, and 79 hours post-ingestion (16.10 mg/L, 12.39 mg/L, and 6.84 mg/L, respectively) revealed a non-linear elimination pattern, with an estimated half-life of ~100 hours between the first two measurements. However, by the third measurement, elimination aligned with previously reported pharmacokinetics. The patient's young age, normal BMI, absence of hepatic disease, and minimal interaction potential with co-ingested antipsychotics did not explain the delayed LTG clearance. We hypothesize that hepatic metabolic pathway saturation led to this non-linear pharmacokinetic behavior. The resolution of delayed elimination corresponded with hepatic enzyme normalization. In drug overdose cases, prolonged consciousness disturbance may indicate an extended drug half-life due to metabolic dysfunction. If recovery exceeds expectations, further evaluation is warranted to identify and address potential causes.

Indexed as

drug metabolismlamotriginemental disordersoverdoseprolonged elimination

Identifiers

PMID40078254
PMCPMC11897840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.